global NGS Sample Preparation market

In the latest report from Emergen Research, the market research report discusses the global NGS Sample Preparation market in depth, and each of the major market segments is examined in depth. In addition to market information, the report provides industry statistics, regional market revenue shares, gross profits, production & distribution costs, and product portfolios related to the global NGS Sample Preparation market. There are also a number of factors influencing industry revenue growth identified in the report, including drivers, opportunities, trends, restraints, challenges, demand and supply ratios, production and consumption patterns, stringent regulatory frameworks, as well as a multitude of other micro- and macro-economic factors.

In addition to detailed market projections, the authors of the report have assessed the NGS Sample Preparation industry quantitatively and qualitatively. In this report, we discuss two of the most important components of this report: SWOT analysis and Porter's Five Forces Analysis. These analyses offer a deep insight into the highly competitive scenario of the industry. In this report, the global NGS Sample Preparation market is analyzed in relation to major regions in the world, such as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Other key aspects of regional markets are also examined in the report, such as revenue growth drivers and restraints, production and consumption patterns, changing consumer preferences, and stringent regulatory regulations.

The global NGS (Next-Generation Sequencing) Sample Preparation market size was USD 2.26 billion in 2024 and is projected to reach around USD 6.07 billion by 2034, growing at a CAGR of 10.4% during the forecast period. The revenue growth in this market is driven by the rapid expansion of sequencing applications in clinical diagnostics, precision oncology, pathogen surveillance, and agricultural genomics—placing mounting emphasis on reliable, high-throughput, and automation-ready sample prep workflows.

NGS sample preparation is a critical bottleneck and cost driver in sequencing pipelines, accounting for 25–40% of total workflow time and consumables cost. As demand rises for faster, cheaper, and clinically scalable NGS assays, there is growing focus on standardizing and automating library preparation, target enrichment, and nucleic acid QC processes.

Key players such as Illumina, Thermo Fisher Scientific, Agilent Technologies, QIAGEN, and Roche are investing in sample prep platforms that enable higher throughput, improved consistency, and compatibility with low-input and degraded samples—especially in liquid biopsy, FFPE tissue, and metagenomics use cases.

Adoption is rising not only in high-complexity labs but also in clinical diagnostic settings, where providers are seeking end-to-end, kit-based solutions that reduce hands-on time, minimize error, and streamline regulatory validation. In parallel, microfluidics, bead-based automation, and enzymatic fragmentation technologies are replacing traditional labor-intensive steps, accelerating TAT and reducing sample loss.

The post-COVID surge in pathogen surveillance, coupled with national investments in genomic infrastructure (e.g., Genomics England, Genome India, NIH’s All of Us), is fueling decentralized NGS workflows across both public health and population genomics. As a result, sample preparation kits tailored for multiplexing, ultra-low input, and minimal manual handling are gaining commercial traction.

With sequencing costs continuing to fall and clinical applications scaling rapidly—from hereditary disease testing to cfDNA-based cancer screening—the sample preparation market is becoming a strategic growth lever for both platform companies and diagnostics developers.

Research Report on the NGS Sample Preparation Market Addresses the Following Key Questions:

Who are the dominant players of the NGS Sample Preparation market?

Which regional market is anticipated to have a high growth rate over the projected period?

What consumer trends and demands are expected to influence the operations of the market players in the NGS Sample Preparation market?

What are the key growth drivers and restraining factors of the NGS Sample Preparation market?

What are the expansion plans and strategic investment plans undertaken by the players to gain a robust footing in the market?

What is the overall impact of the COVID-19 pandemic on the NGS Sample Preparation market and its key segments?

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/12

Competitive Landscape:

The latest study provides an insightful analysis of the broad competitive landscape of the global NGS Sample Preparation market, emphasizing the key market rivals and their company profiles. A wide array of strategic initiatives, such as new business deals, mergers & acquisitions, collaborations, joint ventures, technological upgradation, and recent product launches, undertaken by these companies has been discussed in the report.

Clinical Expansion of NGS and Workflow Automation Demands Are Driving Scalable, Standardized Sample Prep Solutions
The revenue growth in the NGS sample preparation market is being driven by the rapid clinical expansion of next-generation sequencing across oncology, infectious diseases, reproductive health, and inherited genetic disorders. As sequencing moves from research labs into regulated diagnostic settings, demand is accelerating for robust, repeatable, and automation-compatible sample preparation workflows that meet both clinical throughput and regulatory compliance requirements.

In 2024, over 45% of global sequencing volume was tied to clinical applications—up from less than 30% just five years prior—according to data from diagnostic labs and national genomics initiatives. This expansion is putting pressure on sample preparation systems like never before to provide low-input compatibility, sample integrity, and library conversion efficiency, particularly from challenging matrices such as plasma, FFPE tissue, and microbe samples.

Automation is increasingly emerging as a key value driver. Labs implementing high-throughput NGS pipelines are finding themselves more and more reliant on automated liquid handling, bead-based purification, and microfluidic library preparation systems to minimize manual error, shorten turnaround time, and allow 24/7 sample processing. Industry leaders like Thermo Fisher, PerkinElmer, and Agilent are introducing modular sample preparation systems that plug seamlessly into the installed base of sequencers and informatics environments.

Concurrently, multi-analyte panels—integrating DNA, RNA, and epigenetic markers—are becoming increasingly popular in applications including cancer profiling and rare disease diagnosis, further complicating sample preparation. Such a trend encourages demand for integrated reagent kits that enable parallel extraction, multi-omic normalization, and QC validation at speed.

The transition towards liquid biopsy and minimal residual disease (MRD) testing is also driving demand for ultra-sensitive prep technologies that can handle sub-nanogram input with retained variant fidelity. Large OEMs and startups are reacting with enzymatic fragmentation kits, low-bias ligation chemistries, and single-tube workflows intended to be easier to validate and minimize hands-on technician time.

As sequencing becomes integrated into clinical decision-making and evidence generation in real-world settings, NGS sample preparation is transforming from a manual, laboratory-specific operation into a standardized, industrialized process as a competitive driver for labs, diagnostics providers, and sequencing platform vendors.

Innovation & Trends
End-to-End Automation of Sample Prep Workflows
Labs are adopting automated platforms that integrate extraction, fragmentation, library prep, and QC onto a single instrument. For instance, platforms such as Thermo Fisher's Ion Torrent Genexus and Agilent's Magnis are facilitating 24-hour sequencing with minimal hands-on activity.

Enzymatic Fragmentation Replacing Mechanical Shearing
Enzymatic DNA shearing is displacing sonication and bead-based shearing, providing improved control, lower sample loss, and greater reproducibility, particularly for low-input and FFPE samples. NEB and Roche kits are driving clinical genomics adoption.

Low-Input and Ultra-Low Volume Kits for Liquid Biopsy and MRD
Novel chemistries are enabling library construction from <1 ng input DNA, important for circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), and MRD therapies in oncology. Such kits minimize bias and maintain variant fidelity.

Microfluidics and Cartridge-Based Prep Systems
New microfluidic platforms and disposable cartridges are streamlining NGS preparation for decentralized labs, with lower hands-on time, integrated contamination protection, and point-of-care genomics system compatibility.

Multiplexed and Multi-omic Sample Prep Kits
Sample preparation is being redesigned for concurrent DNA/RNA profiling, epigenomics, and transcriptomics in a single process. These kits are picking up steam in cancer diagnostics and spatial genomics studies.

Emergen Research is Offering a full report (Grab a Copy Now) @ https://www.emergenresearch.com/industry-report/ngs-sample-preparation-market

Market Segmentation:

The report bifurcates the NGS Sample Preparation market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.

The NGS sample preparation market is increasingly shaped by automation, platform-specific ecosystem development, and clinical validation. Leading companies are focusing on reducing turnaround times, minimizing input requirements, and expanding compatibility across a broad range of sequencing platforms and sample types. Strategic alliances, OEM bundling, and regional manufacturing are being leveraged to consolidate market share and localize delivery.

Major players like Illumina, Thermo Fisher Scientific, Qiagen, and Agilent are expanding their prep kit portfolios to support low-input, cell-free DNA, FFPE, and single-cell applications. Meanwhile, emerging players are innovating in ultra-fast enzymatic fragmentation, magnetic bead purification, and automation-ready reagent formulations to serve decentralized and resource-limited labs.

Companies are increasingly bundling prep kits with instruments and informatics pipelines, turning sample preparation into a value-added layer within end-to-end sequencing solutions. Competitive strategies also include acquisitions of niche prep technology firms, regulatory clearance of diagnostic-grade kits, and geographic expansion through distributor partnerships and local subsidiaries.

Some of the key companies in the global NGS Sample Preparation market include:
Agilent Technologies
Bio-Rad Laboratories, Inc.
BGI
Biomatters Ltd.
Congenica Ltd
Eurofins Scientific
DNASTAR
Hoffmann-La Roche Ltd
Genomatix GmbH
Thermo Fisher Scientific
Foundation Medicine

Our goal at Emergen Research is to empower businesses with the knowledge and insights necessary to make informed decisions and thrive in today's dynamic business landscape. Our market research content is designed to equip professionals and organizations with comprehensive analyses, actionable recommendations, and a competitive edge to achieve their growth objectives.

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/12

Target Audience of the Global NGS Sample Preparation Market Report:

Key Market Players
Investors
Venture capitalists
Small- and medium-sized and large enterprises
Third-party knowledge providers
Value-Added Resellers (VARs)
Global market producers, distributors, traders, and suppliers
Research organizations, consulting companies, and various alliances interested in this sector
Government bodies, independent regulatory authorities, and policymakers
Key features and benefits of Emergen Research's market research content include:

Comprehensive Analysis: Each piece of content is meticulously researched and provides a detailed analysis of market trends, competitive landscape, consumer behavior, and emerging opportunities. Businesses can leverage this information to identify untapped markets, devise effective marketing strategies, and make data-driven decisions.
Actionable Recommendations: The market research content provides practical insights and actionable recommendations to help businesses enhance their products, services, and overall customer experience. These recommendations are tailored to the specific needs and challenges of each industry, allowing companies to implement strategies that drive growth and profitability.
Expert Insights: Emergen Research's team of industry experts and analysts contribute their in-depth knowledge and expertise to every piece of content. Their insights shed light on industry-specific challenges, best practices, and emerging trends, helping businesses stay ahead of the competition and seize new opportunities.
Timely Updates: The market research content is regularly updated to reflect the latest market trends and dynamics. Subscribers will have access to the most up-to-date information, enabling them to adapt their strategies and stay relevant in today's rapidly evolving business environment.
About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com